Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
SPRING CREEK CAPITAL LLC USAR USA Rare Earth, Inc. 13G/A 4.98% 2y
JPMORGAN CHASE & CO ENR Energizer Holdings, Inc. 13G/A 3.7% 2y
Invesco Ltd. BAB Invesco Exchange-Traded Fund Trust II 13G/A 4.7% 2y
JANUS HENDERSON GROUP PLC WEX WEX Inc. 13G/A 10.1% 2y
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD IIF Morgan Stanley India Investment Fund, Inc. 13G/A 3.6% 2y
JANUS HENDERSON GROUP PLC CCSI Consensus Cloud Solutions, Inc. 13G/A 11.2% 2y
Walleye Capital LLC QOMO Qomolangma Acquisition Corp. Common Stock 13G 12% 2y
First Light Asset Management, LLC FNA Paragon 28, Inc. 13G 12.91% 2y
American Century Investment Management, Inc. SR Spire Inc 13G/A 7.22% 2y
First Trust Capital Management L.P. PLAO Patria Latin American Opportunity Acquisition Corp. Class A Ordinary Shares 13G/A 21.35% 2y
ALLIANCEBERNSTEIN L.P. ARCB Arcbest Corp 13G 10.3% 2y
Invesco Ltd. DBP Invesco DB Precious Metals Fund 13G/A 10.7% 2y
AWM Investment Company, Inc. AMSC American Superconductor Corp 13G/A 4.6% 2y
JPMORGAN CHASE & CO RDN Radian Group Inc 13G/A 4.5% 2y
Invesco Ltd. DBB Invesco Db Base Metals Fund 13G/A 0% 2y
Dodge & Cox AVTR Avantor, Inc. 13G/A 10.1% 2y
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC MAX MediaAlpha, Inc. 13G/A 4% 2y
AWM Investment Company, Inc. VEEE Twin Vee PowerCats, Co. 13G/A 0% 2y
Paul R. Ried Financial Group, LLC SETM Sprott Funds Trust 13G/A 23.6% 2y
METEORA CAPITAL, LLC SMNR Semnur Pharmaceuticals, Inc. 13G 46.62% 2y
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD GF New Germany Fund Inc 13G/A 3.2% 2y
METEORA CAPITAL, LLC TLGYF Tlgy Acquisition Corp 13G/A 3.88% 2y
METEORA CAPITAL, LLC MCAA Mountain & Co. I Acquisition Corp. Class A Ordinary Shares 13G/A 2.4% 2y
PICTON MAHONEY ASSET MANAGEMENT PEGR Project Energy Reimagined Acquisition Corp. Class A Ordinary Share 13G 0% 2y
JPMORGAN CHASE & CO TWST Twist Bioscience Corp 13G/A 4.3% 2y
ORBIMED ADVISORS LLC JANX Janux Therapeutics, Inc. 13D/A 3.8% 2y
EVENTIDE ASSET MANAGEMENT, LLC LXEO Lexeo Therapeutics, Inc. 13G/A 6.65% 2y
CITY OF LONDON INVESTMENT MANAGEMENT CO LTD IHD Voya Emerging Markets High Dividend Equity Fund 13G/A 15.2% 2y
Relative Value Partners Group, LLC JLS Nuveen Mortgage & Income Fund 13G/A 3.9% 2y
METEORA CAPITAL, LLC BLUA BlueRiver Acquisition Corp. 13G/A 0% 2y
BAUPOST GROUP LLC/MA TBPH Theravance Biopharma, Inc. 13G/A 6.12% 2y
JPMORGAN CHASE & CO MSA MSA Safety Inc 13G/A 4.5% 2y
Invesco Ltd. DBE Invesco DB Energy Fund 13G/A 0% 2y
Invesco Ltd. DVVY Invesco Actively Managed Exchange-Traded Fund Trust 13G/A 29.6% 2y
Sanken Electric Co., Ltd. ALGM Allegro Microsystems, Inc. 13G/A 30.8% 2y
Saba Capital Management, L.P. BTX BlackRock Technology & Private Equity Term Trust 13D/A 24.87% 2y
venBio Global Strategic Fund III, L.P. ELEV Elevation Oncology, Inc. Common stock 13D/A 3.4% 2y
Galkin Vladimir JBLU Jetblue Airways Corp 13G/A 7.4% 2y
Elizabeth Paige Laurie FMBH First Mid Bancshares, Inc. 13D/A 5.3% 2y
Value Base Ltd. VLN Valens Semiconductor Ltd. 13D/A 19.55% 2y
Maritime Investors Corp. PXS Pyxis Tankers Inc. 13D/A 56.1% 2y
Yakira Capital Management, Inc. NOVV Nova Vision Acquisition Corp. Ordinary share 13G/A 0% 2y
Saba Capital Management, L.P. GLO Clough Global Opportunities Fund 13D 5.03% 2y
Versant Venture Capital VI, L.P. BDTX Black Diamond Therapeutics, Inc. 13D/A 7.7% 2y
Heard Capital LLC ATEX Anterix Inc. 13D/A 9.4% 2y
Berkshire Hathaway Inc DVA Davita Inc. 13D/A 43% 2y
Tether Holdings Limited BTDR Bitdeer Technologies Group 13D/A 27.2% 2y
Kent Lake Capital LLC RGS Regis Corp 13G/A 4.9% 2y
Madeleine Charging B.V. ALLG Allego N.V. 13D 91.5% 2y
Lightbank Asset Management, LLC SBIG SBIG Holdings, Inc. 13D 26% 2y